Increased expression of tumor necrosis factor-α messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase

被引:55
作者
Akazawa, A [1 ]
Sakaida, I [1 ]
Higaki, S [1 ]
Kubo, Y [1 ]
Uchida, K [1 ]
Okita, K [1 ]
机构
[1] Yamaguchi Univ, Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi 7558505, Japan
关键词
tumor necrosis factor-alpha messenger RNA; inflammatory bowel disease; quantitative RT-PCR;
D O I
10.1007/s005350200048
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Tumor necrosis factor-alpha (TNF-alpha), may be involved in the pathogenesis of inflammatory bowel diseases (IBDs). The aim of this study was to evaluate the effect of TNF-alpha on the inflammatory activity of IBD. Methods. TNF-alpha mRNA expression in intestinal mucosal biopsy specimens from IBD patients [ulcerative colitis (UC), n = 54; and Crohn's disease (CD), n = 11] was analyzed using a competitive polymerase chain reaction. The degree of macrophage infiltration was analyzed by immunohistochemistry, using an antihuman CD68 antibody. Results. TNF-alpha mRNA expression was increased in UC patients, corresponding to the inflammatory activity. However, in CD, TNF-alpha mRNA expression was not correlated with the endoscopic findings. Conclusions. We clarified that TNF-alpha mRNA expression was responsible for the inflammatory activity in UC. However, TNF-alpha mRNA expression was not correlated with the mucosal injury in CD.
引用
收藏
页码:345 / 353
页数:9
相关论文
共 38 条
[1]   Tumor necrosis factor α antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis [J].
Baert, FJ ;
D'Haens, GR ;
Peeters, M ;
Hiele, MI ;
Schaible, TF ;
Shealy, D ;
Geboes, K ;
Rutgeerts, PJ .
GASTROENTEROLOGY, 1999, 116 (01) :22-28
[2]   TUMOR-NECROSIS-FACTOR-ALPHA IN STOOL AS A MARKER OF INTESTINAL INFLAMMATION [J].
BRAEGGER, CP ;
NICHOLLS, S ;
MURCH, SH ;
STEPHENS, S ;
MACDONALD, TT .
LANCET, 1992, 339 (8785) :89-91
[3]   TUMOR-NECROSIS-FACTOR ALPHA-PRODUCING CELLS IN THE INTESTINAL-MUCOSA OF CHILDREN WITH INFLAMMATORY BOWEL-DISEASE [J].
BREESE, EJ ;
MICHIE, CA ;
NICHOLLS, SW ;
MURCH, SH ;
WILLIAMS, CB ;
DOMIZIO, P ;
WALKERSMITH, JA ;
MACDONALD, TT .
GASTROENTEROLOGY, 1994, 106 (06) :1455-1466
[4]   DETECTION OF MESSENGER-RNAS FOR MACROPHAGE PRODUCTS IN INFLAMMATORY BOWEL-DISEASE BY INSITU HYBRIDIZATION [J].
CAPPELLO, M ;
KESHAV, S ;
PRINCE, C ;
JEWELL, DP ;
GORDON, S .
GUT, 1992, 33 (09) :1214-1219
[5]  
CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532
[6]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[7]  
DEEM RL, 1991, CLIN EXP IMMUNOL, V83, P79
[8]   TUMOR-NECROSIS-FACTOR ANTIBODY TREATMENT IN CROHNS-DISEASE [J].
DERKX, B ;
TAMINIAU, J ;
RADEMA, S ;
STRONKHORST, A ;
WORTEL, C ;
TYTGAT, G ;
VANDEVENTER, S .
LANCET, 1993, 342 (8864) :173-174
[9]   Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies [J].
Dionne, S ;
Hiscott, J ;
DAgata, I ;
Duhaime, A ;
Seidman, EG .
DIGESTIVE DISEASES AND SCIENCES, 1997, 42 (07) :1557-1566
[10]   SPONTANEOUS RELEASE OF INTERFERON-GAMMA BY INTESTINAL LAMINA PROPRIA LYMPHOCYTES IN CROHNS-DISEASE - KINETICS OF INVITRO RESPONSE TO INTERFERON-GAMMA INDUCERS [J].
FAIS, S ;
CAPOBIANCHI, MR ;
PALLONE, F ;
DIMARCO, P ;
BOIRIVANT, M ;
DIANZANI, F ;
TORSOLI, A .
GUT, 1991, 32 (04) :403-407